EVALUATION AND OUTCOMES OF MIDODRINE, OCTREOTIDE, AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME

被引：0
|
作者：
Patel, Jignesh [1 ]
Tran, Michelle [2 ]
Trujillo, Nalea [3 ]
Mata, Kenneth [4 ]
Chan, Patrick [1 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[2] Univ Calif Irvine, Med Ctr, Irvine, CA USA
[3] Stanford Hlth Care, Newark, CA USA
[4] Kaiser Permanente Med Ctr, Los Angeles, CA USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
950
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF HEPATORENAL SYNDROME WITH OCTREOTIDE ALBUMIN AND MIDODRINE
    Jain, Akhil
    Hunsicker, Lawrence G.
    Voigt, Michael D.
    HEPATOLOGY, 2008, 48 (04) : 1086A - 1086A
  • [2] Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    Wong, F
    Pantea, L
    Sniderman, K
    HEPATOLOGY, 2004, 40 (01) : 55 - 64
  • [3] Octreotide, midodrine, and albumin, triple therapy is effective in reversing Hepatorenal Syndrome.
    Hassanein, TI
    Abdeen, O
    El-Tahawy, M
    Hart, M
    Khanna, A
    Mehta, R
    HEPATOLOGY, 2001, 34 (04) : 542A - 542A
  • [4] Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate
    Hiruy, Aklil
    Nelson, Joelle
    Zori, Andreas
    Morelli, Giuseppe
    Cabrera, Roniel
    Kamel, Amir
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (01) : 102 - 106
  • [5] TERLIPRESSIN VERSUS MIDODRINE/OCTREOTIDE FOR HEPATORENAL SYNDROME
    Juang, Paul
    Yeary, Julianne
    Barker, Skyler
    Owen, Emily
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [6] Efficacy of Midodrine, Octreotide and Albumin (MOA) for Type I Hepatorenal Syndrome (HRS 1)
    Liu, Eashen
    Singhal, Pooja
    Karim, Yasmin K.
    Barton, Franca B.
    Lewis, James H.
    GASTROENTEROLOGY, 2011, 140 (05) : S959 - S959
  • [7] Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
    Cavallin, Marta
    Kamath, Patrick S.
    Merli, Manuela
    Fasolato, Silvano
    Toniutto, Pierluigi
    Salerno, Francesco
    Bernardi, Mauro
    Romanelli, Roberto Giulio
    Colletta, Cosimo
    Salinas, Freddy
    Di Giacomo, Antonio
    Ridola, Lorenzo
    Fornasiere, Ezio
    Caraceni, Paolo
    Morando, Filippo
    Piano, Salvatore
    Gatta, Angelo
    Angeli, Paolo
    HEPATOLOGY, 2015, 62 (02) : 567 - 574
  • [8] A Case for Norepinephrine versus Octreotide and Midodrine in Hepatorenal Syndrome
    Anong, John
    Litchfield, John
    Reddy, Chakradhar
    Borthwick, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S120 - S120
  • [9] Combination Treatment With Octreotide, Midodrine, and Albumin Improves Survival in Patients With Type 1 and Type 2 Hepatorenal Syndrome
    Skagen, Catherine
    Einstein, Michael
    Lucey, Michael R.
    Said, Adnan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (07) : 680 - 685
  • [10] MEAN ARTERIAL PRESSURE AS AN INDEPENDENT PREDICTOR OF RESPONSE TO THERAPY WITH OCTREOTIDE, MIDODRINE, AND ALBUMIN IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME
    Brown, Patrick R.
    Lenhart, Adrienne
    Khan, Omar
    Alimirah, Maryam
    Abdulla, Hafsa
    Salgia, Reena
    Uduman, Junior
    GASTROENTEROLOGY, 2018, 154 (06) : S1182 - S1182
12345